ENDRA Life Sciences Inc.
NDRANasdaq
$4.99
↓ -5.3%Jul 17 close · end-of-day
Price
1Y↓ -31.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.0M
Enterprise Value
$6.0M
P/E
—
P/S
—
P/B
3.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$7.3M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-408.7%
ROIC
-285.9%
Debt / Equity
—
Net Cash
—
Return 1Y
-33.0%
Company profile
ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology. Technology transmits sound waves, which bounce off tissues, organs, and blood in the body. Thermoablative surgery, vascular imaging, and tissue perfusion technologies also offer diagnostic imaging technologies.
- CEO
- Francois Michelon
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 20
- Headquarters
- Michigan
- Website
- endrainc.com
Management & directors
- Jacroux RichardChief Financial Officer
- Tokman Alexander YChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
NDRA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$1.09↓ -41.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | — | — | — | — | — |
| Gross profit | $0.00 | — | — | — | — | — |
| Operating income | -$11.5M | -$11.5M | -$13.2M | -$10.5M | -$10.8M | -$5.8M |
| Net income | -$11.7M | -$11.2M | -$13.2M | -$10.1M | -$11.5M | -$7.0M |
| Diluted EPS | — | — | — | -$2,766.85 | -$56.94 | -$8.93 |
| Operating cash flow | -$10.7M | -$11.1M | -$12.8M | -$9.5M | -$7.4M | -$5.2M |
| Free cash flow | -$10.8M | -$11.2M | -$13.0M | -$9.6M | -$7.4M | -$5.2M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$2.2M | -$1.5M | -$4.3M | -$1.5M | -$1.3M | -$1.4M | -$1.6M | -$2.2M |
| Net income | -$2.2M | -$2.4M | -$4.1M | -$1.0M | -$1.2M | -$1.6M | -$3.2M | -$1.3M |
| Diluted EPS | — | -$9.54 | — | -$1.86 | — | -$2.10 | — | -$1.09 |
| Operating cash flow | -$2.1M | -$1.7M | -$1.5M | -$1.3M | -$1.1M | -$1.2M | -$1.6M | -$1.1M |
| Free cash flow | -$2.1M | -$1.7M | -$1.5M | -$1.3M | -$1.1M | -$1.2M | -$1.6M | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jun 25, 2026
- 25d agoTop Midday Declinersfinance.yahoo.com
- 25d agoASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Dealstocktwits.com
- 25d agoASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financingfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-02 | Tokman Alexander Y· Chief Executive Officer | Award | 26,921 | $0.00 | $0.00 | filing |
| 2026-03-02 | Jacroux Richard· Chief Financial Officer | Award | 13,461 | $0.00 | $0.00 | filing |
| 2026-01-21 | DIGIANDOMENICO ANTHONY | Award | 60,324 | $0.00 | $0.00 | filing |
| 2026-01-21 | Harsh Michael | Award | 60,324 | $0.00 | $0.00 | filing |
| 2026-01-21 | Jacroux Richard· Chief Financial Officer | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-01-21 | Basenese Lou | Award | 60,324 | $0.00 | $0.00 | filing |
| 2026-01-21 | Tokman Alexander Y· Chief Executive Officer | Award | 75,000 | $0.00 | $0.00 | filing |
| 2025-10-10 | DIGIANDOMENICO ANTHONY | Award | 70,822 | $7.06 | $500,003.32 | filing |
Latest 8 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.